Pacific Edge (ASX:PEB) Other Long Term Assets: A$-0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:PEB Pacific Edge Ltd ASX:PEB
38 GF Score
Price A$0.21
GF Value A$0.05
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Pacific Edge Other Long Term Assets?

Pacific Edge ASX:PEB 38 Other Long Term Assets is A$-0.00 Mil as of Mar. 2026. GuruFocus rates ASX:PEB with a GF Score™ of 38/100 and a GF Value™ of A$0.05 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Pacific Edge's other long-term assets for the quarter that ended in Mar. 2026 was A$-0.00 Mil.

Pacific Edge's quarterly other long-term assets declined from Mar. 2025 (A$0.00 Mil) to Sep. 2025 (A$-0.00 Mil) but then stayed the same from Sep. 2025 (A$-0.00 Mil) to Mar. 2026 (A$-0.00 Mil).

Pacific Edge's annual other long-term assets increased from Mar. 2024 (A$-0.00 Mil) to Mar. 2025 (A$0.00 Mil) but then declined from Mar. 2025 (A$0.00 Mil) to Mar. 2026 (A$-0.00 Mil).

Pacific Edge Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Pacific Edge's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Edge Other Long Term Assets Chart

Pacific Edge Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.00 -0.00 0.00 -0.00

Pacific Edge Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.00 -0.00 0.00 -0.00 -0.00
ASX:PEB
38GF Score
Pacific Edge Ltd ASX:PEB
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pacific Edge Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of A$-0.00 Mil mean?
Pacific Edge (ASX:PEB) has a Other Long Term Assets of A$-0.00 Mil as of Mar. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Pacific Edge and its competitors.
Is Pacific Edge's Other Long Term Assets too high?
Pacific Edge's current Other Long Term Assets is A$-0.00 Mil. Overall, Pacific Edge has a GF Score™ of 38/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Pacific Edge's Other Long Term Assets compare to TMO and DHR?
Pacific Edge's Other Long Term Assets of A$-0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Medical Diagnostics & Research company?
A good Other Long Term Assets depends on the Medical Diagnostics & Research industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Pacific Edge and its competitors. Pacific Edge's current Other Long Term Assets is A$-0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pacific Edge stock overvalued right now?
Based on GuruFocus' analysis, Pacific Edge (ASX:PEB) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.05, compared to a current price of A$0.21 — trading 320% above its estimated fair value. The current Other Long Term Assets is A$-0.00 Mil. Pacific Edge's overall GF Score™ is 38/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Pacific Edge (ASX:PEB), the current Other Long Term Assets is A$-0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacific Edge (ASX:PEB) Overvalued in 2026?

Based on GuruFocus' analysis, Pacific Edge stock appears to be overvalued. The current stock price of A$0.21 is trading 320% above its estimated GF Value™ of A$0.05. GuruFocus considers Pacific Edge to be Significantly Overvalued.

Key valuation signals for ASX:PEB:

  • Other Long Term Assets: A$-0.00 Mil
  • GF Value™: A$0.05 vs. price of A$0.21 (320% above fair value)
  • GF Score™: 38/100 with 5 warning signs

No single metric tells the full story. See the ASX:PEB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacific Edge Business Description

Address 87 Saint David Street, P.O. Box 56, Dunedin, STL, NZL, 9016
Pacific Edge Ltd is a New Zealand-based company involved in researching, developing, and commercialising new diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. It operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses internationally; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, which generates maximum revenue, New Zealand, and the Rest of the World.
38GF Score

Get the complete analysis for ASX:PEB

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.21
Price
A$0.05
GF Value